CVS » Topics » Submission of Matters to a Vote of Security Holders

This excerpt taken from the CVS 10-Q filed Jul 31, 2008.

Submission of Matters to a Vote of Security Holders

The following matters were submitted to a vote of security holders at our Annual Meeting of Stockholders which was held on Wednesday, May 7, 2008 in Woonsocket, Rhode Island.

 

     For    Against    Abstained    Broker
Non-Votes

1. The election, for one-year terms, of all persons nominated for directors, as set forth in the Company’s proxy statement dated March 28, 2008, was approved by the following votes:

 

                    Edwin M. Banks

                    C. David Brown II

                    David W. Dorman

                    Kristen Gibney Williams

                    Marian L. Heard

                    William H. Joyce

                    Jean-Pierre Millon

                    Terrence Murray

                    C.A. Lance Piccolo

                    Sheli Z. Rosenberg

                    Thomas M. Ryan

                    Richard J. Swift

   1,158,184,562

1,169,033,936

1,119,442,248

1,175,264,010

1,161,685,298

1,166,721,157

1,174,663,732

1,164,208,664

1,162,275,878

1,138,032,559

1,163,947,494

1,170,839,460

   27,930,122

17,038,013

66,561,487

10,447,406

24,057,160

18,732,205

10,981,727

21,668,864

23,474,896

44,247,836

22,046,412

14,839,386

   —  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

   —  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

—  

     For    Against    Abstained    Broker
Non-Votes

2. Ratification of the appointment of Ernst &Young LLP as the Company’s independent registered public accounting firm for the 2008 fiscal year, was approved by the following vote:

   1,179,436,206    6,638,164    11,707,307    —  

3. Stockholder proposal regarding special shareholder meetings, as set forth in the Company’s proxy statement dated March 28, 2008, was rejected by the following vote:

   501,107,111    537,090,591    31,784,340    385,262,158

4. Stockholder proposal regarding tax gross-up payments, as set forth in the Company’s proxy statement dated March 28, 2008, was rejected by the following vote:

   514,906,805    470,247,984    84,827,254    385,262,157

5. Stockholder proposal regarding political contributions and expenditures, as set forth in the Company’s proxy statement dated March 28, 2008, was rejected by the following vote:

   350,471,655    560,985,044    158,525,350    385,262,151

 

40


Table of Contents
Part II    Item 5

 

This excerpt taken from the CVS 10-Q filed Aug 8, 2007.

Submission of Matters to a Vote of Security Holders

The results of matters submitted to a vote of security holders at our Annual Meeting of Stockholders, which was held on Wednesday, May 9, 2007, are incorporated by reference to Item 8.01 of CVS Caremark Corporations Current Report on Form 8-K dated May 15, 2007.

 

46


Table of Contents

11. Part II

 

  

Item 6

 

 

This excerpt taken from the CVS 10-Q filed May 8, 2007.

Submission of Matters to a Vote of Security Holders

The following matters were submitted to a vote of security holders at a special meeting, which was held on Thursday, March 15, 2007 in Woonsocket, Rhode Island:

 

          For    Against    Abstained   

Broker

Non-Votes

1.

   Proposal to approve the amendments to CVS’ Amended and Restated Certificate of Incorporation, which is referred to as the CVS charter, effective upon completion of the merger, to increase the authorized number of shares of CVS common stock from 1 billion to 3.2 billion and to change the name of CVS Corporation to “CVS/Caremark Corporation”.    572,636,492    45,135,797    5,995,843    —  

2.

   Proposal to approve the issuance of shares of CVS/Caremark common stock to stockholders of Caremark Rx, Inc. on the terms and conditions set out in the Agreement and Plan of Merger dated as of November 1, 2006, as amended.    572,737,945    44,683,923    6,346,264    —  

3.

   Proposal to approve an adjournment or postponement of the special meeting, including if necessary, to solicit additional proxies in favor of the foregoing proposals.    517,539,027    99,882,358    6,346,747    —  

 

37


Table of Contents

Part II

 

This excerpt taken from the CVS 10-K filed Feb 27, 2007.

Item 4.              Submission of Matters to a Vote of Security Holders

No matters were submitted to a vote of security holders during the fourth quarter of the fiscal year ended December 30, 2006.

18




Executive Officers of the Registrant

Executive Officers of the Registrant

The following sets forth the name, age and biographical information for each of our executive officers as of February 21, 2007. In each case the officer’s term of office extends to the date of the board of directors meeting following the next annual meeting of stockholders of the Company. Previous positions and responsibilities held by each of the executive officers over the past five years are indicated below:

Chris W. Bodine, age 51, Executive Vice President and President of CVS Health Services since January 2007; Executive Vice President—Merchandising and Marketing of CVS Corporation and CVS Pharmacy, Inc. from February 2002 to January 2007; Senior Vice President—Merchandising of CVS Pharmacy, Inc. from February 2000 to February 2002.

V. Michael Ferdinandi, age 56, Senior Vice President—Human Resources and Corporate Communications of CVS Corporation and CVS Pharmacy, Inc. since April 2002; Vice President—Human Resources, Organizational Development of CVS Pharmacy Inc. from April 1999 to April 2002.

Larry J. Merlo, age 51, Executive Vice President and President of CVS/pharmacy – Retail since January 2007; Executive Vice President—Stores of CVS Corporation from April 2000 to January 2007 and Executive Vice President—Stores of CVS Pharmacy, Inc. from March 1998 to January 2007.

Paula A. Price, age 45, Senior Vice President and Controller of CVS Corporation and CVS Pharmacy, Inc. since July 2006; Senior Vice President and Chief Financial Officer for the Institutional Trust Services division of JPMorgan Chase & Co. from 2003 to 2005; Managing Director and Head of Corporate Strategy and Business Development of JPMorgan Chase from 2002 to 2003.

David B. Rickard, age 60, Executive Vice President, Chief Financial Officer and Chief Administrative Officer of CVS Corporation and CVS Pharmacy, Inc. since September 1999; director of Harris Corporation.

Thomas M. Ryan, age 54, President and Chief Executive Officer of CVS Corporation since May 1998 and Chairman of CVS Corporation since April 1999; also President and CEO of CVS Pharmacy, Inc. since 1994; director of Bank of America Corporation, and Yum! Brands, Inc.

Douglas A. Sgarro, age 47, Executive Vice President—Strategy and Chief Legal Officer of CVS Corporation and CVS Pharmacy, Inc. since March 2004 and President of CVS Realty Co., a real estate development company and a division of CVS Pharmacy, Inc., since October 1999; Senior Vice President and Chief Legal Officer of CVS Corporation from April 2000 to March 2004.

19




PART II

This excerpt taken from the CVS 10-Q filed Aug 8, 2006.

Submission of Matters to a Vote of Security Holders

The following matters were submitted to a vote of security holders at our Annual Meeting of Stockholders, which was held on Thursday, May 11, 2006 in Woonsocket, Rhode Island:

 

          For    Withheld    Abstained   

Broker

Non-Votes

1.

   The election, for one-year terms, of all persons nominated for directors, as set forth in the Company’s proxy statement dated March 24, 2006, was approved by the following votes:            
  

W. Don Cornwell

   654,199,413    16,097,046    —      —  
  

David W. Dorman

   662,853,644    7,442,815    —      —  
  

Thomas P. Gerrity

   649,935,235    20,361,224    —      —  
  

Marian L. Heard

   661,644,899    8,651,560    —      —  
  

William H. Joyce

   655,522,209    14,774,250    —      —  
  

Terrence Murray

   661,223,005    9,073,454    —      —  
  

Sheli Z. Rosenberg

   648,288,291    22,008,168    —      —  
  

Thomas M. Ryan

   655,446,778    14,849,681    —      —  
  

Alfred J. Verrecchia

   639,086,117    31,210,342    —      —  
          For    Against    Abstained   

Broker

Non-Votes

2.

   Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2006, was approved by the following vote:    651,892,961    13,731,231    4,672,267    —  

3.

   Stockholder proposal regarding election of directors by majority rather than plurality vote, as set forth in the Company’s proxy statement dated March 24, 2006, was rejected by the following vote:    282,933,493    284,167,206    8,000,000    95,195,680

4.

   Stockholder proposal regarding certain retirement benefits for senior executives, as set forth in the Company’s proxy statement dated March 24, 2006, was withdrawn by the stockholder prior to the meeting:    —      —      —      —  

5.

   Stockholder proposal regarding independence of the Chairman of the Board, as set forth in the Company’s proxy statement dated March 24, 2006, was rejected by the following vote:    227,925,578    340,762,906    6,417,295    95,190,680

6.

   Stockholder proposal regarding formulation of cosmetics sold at CVS, as set forth in the Company’s proxy statement dated March 24, 2006, was rejected by the following vote:    50,254,632    456,464,813    68,386,334    95,190,680

 

29


Table of Contents
Part II    Item 6
This excerpt taken from the CVS 10-K filed Mar 14, 2006.

Item 4. Submission of Matters to a Vote of Security Holders

No matters were submitted to a vote of security holders during the fourth quarter of the fiscal year ended December 31, 2005.

Executive Officers of the Registrant

Executive Officers of the Registrant

The following sets forth the name, age and biographical information for each of our executive officers as of March 14, 2006. In each case the officer’s term of office extends to the date of the board of directors meeting following the next annual meeting of stockholders of the Company. Previous positions and responsibilities held by each of the executive officers over the past five years are indicated below:

Chris Bodine, age 50, Executive Vice President—Merchandising and Marketing of CVS Corporation and CVS Pharmacy, Inc. since February 1, 2002; Senior Vice President—Merchandising of CVS Pharmacy, Inc. from February 2000 to February 2002.

V. Michael Ferdinandi, age 55, Senior Vice President—Human Resources and Corporate Communications of CVS Corporation and CVS Pharmacy, Inc. since April 2002; Vice President—Human Resources, Organizational Development of CVS Pharmacy Inc. from April 1999 to April 2002.

Larry J. Merlo, age 50, Executive Vice President—Stores of CVS Corporation since April 2000 and Executive Vice President—Stores of CVS Pharmacy, Inc. since March 1998.

David B. Rickard, age 59, Executive Vice President, Chief Financial Officer and Chief Administrative Officer of CVS Corporation and CVS Pharmacy, Inc. since September 1999; director of Harris Corporation since October 2001.

Thomas M. Ryan, age 53, President and Chief Executive Officer of CVS Corporation since May 1998 and Chairman of CVS Corporation since April 1999; also President and CEO of CVS Pharmacy, Inc. since 1994; director of Bank of America Corporation, and Yum! Brands, Inc.; and director of Reebok International Ltd. until its acquisition by Adidas-Soloman AG was completed in January 2006.

Douglas A. Sgarro, age 46, Executive Vice President—Strategy and Chief Legal Officer of CVS Corporation and CVS Pharmacy, Inc. since March 2004 and President of CVS Realty Co., a real estate development company and a division of CVS Pharmacy, Inc., since October 1999; Senior Vice President and Chief Legal Officer of CVS Corporation from April 2000 to March 2004.

Gregory S. Weishar, age 51, Vice President of CVS Corporation since April 2002, and Chief Executive Officer and President of PharmaCare Management Services, Inc., our PBM, since December 1998.

 

9


Table of Contents

PART II

This excerpt taken from the CVS 10-Q filed Aug 9, 2005.

Submission of Matters to a Vote of Security Holders

 

The following matters were submitted to a vote of security holders at our Annual Meeting of Stockholders, which was held on Thursday, May 12, 2005 in Woonsocket, Rhode Island:

 

            For

   Withheld

   Abstained

  

Broker

Non-Votes


1.

     The election, for one-year terms, of all persons nominated for directors, as set forth in the Company’s proxy statement dated March 25, 2005, was approved by the following votes:                    
      

W. Don Cornwell

Thomas P. Gerrity

Stanley P. Goldstein

Marian L. Heard

William H. Joyce

Terrence Murray

Sheli Z. Rosenberg

Thomas M. Ryan

Alfred J. Verrecchia

   330,100,484
332,242,827
331,384,188
327,458,601
263,643,617
330,858,820
330,346,611
330,318,809
325,722,253
   10,009,986
7,867,643
8,726,282
12,651,869
76,466,853
9,251,650
9,763,859
9,791,661
14,388,217
   —  
—  
—  
—  
—  
—  
—  
—  
—  
   —  
—  
—  
—  
—  
—  
—  
—  
—  
            For

   Against

   Abstained

  

Broker

Non-Votes


2.

     Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2005, was approved by the following vote:    332,109,582    5,780,313    2,220,575    —  

3.

     Stockholder proposal regarding election of directors by majority rather than plurality vote, as set forth in the Company’s proxy statement dated March 25, 2005, was rejected by the following vote:    110,699,383    191,059,738    3,278,586    35,072,763

4.

     Stockholder proposal regarding performance and time-based restricted shares, as set forth in the Company’s proxy statement dated March 25, 2005, was rejected by the following vote:    26,450,159    274,895,218    3,692,330    35,072,763

5.

     Stockholder proposal regarding non-deductible executive compensation, as set forth in the Company’s proxy statement dated March 25, 2005, was rejected by the following vote:    18,160,569    283,295,698    3,581,440    35,072,763

 

22


Table of Contents
Part II   Item 5

This excerpt taken from the CVS 10-K filed Mar 16, 2005.

Item 4. Submission of Matters to a Vote of Security Holders

 

No matters were submitted to a vote of security holders during the fourth quarter of the fiscal year ended January 1, 2005.

 

Executive Officers of the Registrant

 

Executive Officers of the Registrant

 

The following sets forth the name, age and biographical information for each of our executive officers as of March 15, 2005. In each case the officer’s term of office extends to the date of the board of directors meeting following the next annual meeting of stockholders of the Company. Previous positions and responsibilities held by each of the executive officers over the past five years are indicated below:

 

Chris Bodine, age 49, Executive Vice President—Merchandising and Marketing of CVS Corporation and CVS Pharmacy, Inc. since February 1, 2002; Senior Vice President—Merchandising of CVS Pharmacy, Inc. from February 2000 to February 2002.

 

V. Michael Ferdinandi, age 54, Senior Vice President—Human Resources and Corporate Communications of CVS Corporation and CVS Pharmacy, Inc. since April 2002; Vice President—Human Resources, Organizational Development of CVS Pharmacy Inc. from April 1999 to April 2002.

 

7


Table of Contents

Larry J. Merlo, age 49, Executive Vice President—Stores of CVS Corporation since April 2000 and Executive Vice President—Stores of CVS Pharmacy, Inc. since March 1998.

 

David B. Rickard, age 58, Executive Vice President, Chief Financial Officer and Chief Administrative Officer of CVS Corporation and CVS Pharmacy, Inc. since September 1999; director of Harris Corporation since October 2001 and May Department Stores Company since January 2005.

 

Thomas M. Ryan, age 52, President and Chief Executive Officer of CVS Corporation since May 1998 and Chairman of CVS Corporation since April 1999; also President and CEO of CVS Pharmacy, Inc. since 1994; director of Bank of America Corporation, Reebok International Ltd. and Yum! Brands, Inc.

 

Douglas A. Sgarro, age 45, Executive Vice President—Strategy and Chief Legal Officer of CVS Corporation and CVS Pharmacy, Inc. since March 2004 and President of CVS Realty Co., a real estate development company and a division of CVS Pharmacy, Inc., since October 1999; Senior Vice President and Chief Legal Officer of CVS Corporation from April 2000 to March 2004.

 

Larry D. Solberg, age 57, Senior Vice President—Finance and Controller of CVS Corporation since April 2000 and Senior Vice President—Finance and Controller of CVS Pharmacy, Inc. since March 1996.

 

Gregory S. Weishar, age 50, Vice President of CVS Corporation since April 2002, and Chief Executive Officer and President of PharmaCare Management Services, Inc., our PBM, since December 1998.

 

PART II

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki